We are live on ! Find out more
BHC icon

Bausch Health

582 hedge funds and large institutions have $64.4B invested in Bausch Health in 2015 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 186 increasing their positions, 224 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 85 | Existing positions closed: 55

12% more capital invested

Capital invested by funds: $57.6B → $64.4B (+$6.74B)

5% more funds holding

Funds holding: 556582 (+26)

2% more funds holding in top 10

Funds holding in top 10: 8789 (+2)

0.39% more ownership

Funds ownership: 84.48%84.87% (+0.39%)

17% less repeat investments, than reductions

Existing positions increased: 186 | Existing positions reduced: 224

54% less call options, than puts

Call options by funds: $889M | Put options by funds: $1.94B

Holders
582
Holders Change
+26
Holders Change %
+4.68%
% of All Funds
15.68%
Holding in Top 10
89
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+2.3%
% of All Funds
2.4%
New
85
Increased
186
Reduced
224
Closed
55
Calls
$889M
Puts
$1.94B
Net Calls
-$1.06B
Net Calls Change
-$66.4M
Name Holding Trade Value Shares
Change
Change in
Stake
ESG
76
Emerging Sovereign Group
New York
$160M +$1.66M +7,489 +1%
WIM
77
Weitz Investment Management
Nebraska
$159M -$44.5M -200,531 -22%
WBC
78
Westpac Banking Corp
Australia
$155M -$9.45M -42,618 -6%
Canada Pension Plan Investment Board
79
Canada Pension Plan Investment Board
Ontario, Canada
$154M -$20.1M -90,855 -12%
C
80
Consulta
United Kingdom
$144M
APG Asset Management
81
APG Asset Management
Netherlands
$140M -$6.59M -29,735 -5%
Alkeon Capital Management
82
Alkeon Capital Management
New York
$135M +$90.3M +407,500 +204%
Ameriprise
83
Ameriprise
Minnesota
$134M +$64.6M +291,244 +94%
MAA
84
Managed Account Advisors
New Jersey
$133M +$11.9M +53,551 +10%
RCM
85
Roystone Capital Management
New York
$132M -$78.7M -355,000 -37%
BWCA
86
Brenner West Capital Advisors
New York
$130M -$25.1M -113,149 -16%
Credit Agricole
87
Credit Agricole
France
$124M +$35.7M +161,171 +41%
BG
88
BlackRock Group
United Kingdom
$124M +$27.7M +125,146 +29%
BIM
89
BlackRock Investment Management
Delaware
$122M -$6.81M -30,728 -5%
Loomis, Sayles & Company
90
Loomis, Sayles & Company
Massachusetts
$121M -$225K -1,014 -0.2%
CS
91
Credit Suisse
Switzerland
$120M -$3.1M -13,966 -3%
O
92
OppenheimerFunds
New York
$120M +$7.95M +35,847 +7%
PIC
93
PCJ Investment Counsel
Ontario, Canada
$117M -$16.2M -73,071 -12%
AC
94
Alleghany Corporation
New York
$114M +$69.3M +312,500 +156%
AIM
95
Assured Investment Management
New York
$112M -$93.7M -422,522 -46%
Citadel Advisors
96
Citadel Advisors
Florida
$95.7M +$60.4M +272,342 +172%
State of Tennessee, Department of Treasury
97
State of Tennessee, Department of Treasury
Tennessee
$95.2M
AA
98
Antipodean Advisors
New York
$91.8M -$33.5M -151,000 -27%
TCIM
99
TIAA CREF Investment Management
New York
$90.2M +$86.7M +391,074 +2,607%
RG
100
Redmile Group
California
$85.4M +$25.7M +115,987 +43%

BHC Hedge Fund Activity: Q2 2015 in Review

582 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2015, worth a combined $64.4B — up 12% from $57.6B a quarter earlier.

Buyers outnumbered sellers: 85 funds opened new BHC positions and 55 closed out — a net gain of 30 holders — while 186 added to existing stakes and 224 trimmed.

The largest buyer was Paulson & Co, adding an estimated $1.54B. The largest seller was ValueAct Holdings, cutting an estimated $973M.

  • 582 institutional investors held Bausch Health (BHC) as of Q2 2015, up from 556 in Q1 2015.
  • Funds reported $64.4B of Bausch Health stock for Q2 2015, up 12% quarter-over-quarter.
  • 85 funds opened new Bausch Health positions in Q2 2015 and 55 closed out, a net change of +30 holders.
  • The largest Bausch Health buyer in Q2 2015 was Paulson & Co, an estimated $1.54B added.
  • The largest Bausch Health seller in Q2 2015 was ValueAct Holdings, an estimated $973M sold.

Based on aggregated 13F filings for Q2 2015.